Liquid biopsy is indeed a non-invasive diagnostic method that has gained significant attention in the field of medicine and healthcare. It involves detecting and analyzing biomarkers in bodily fluids, such as blood, urine, or cerebrospinal fluid, to provide valuable information for diagnosing, prognosis, and monitoring various diseases, particularly cancer. Addressing the need for innovative approaches in the diagnosis and treatment of cancer, researchers are focused on identifying new biomarkers for diagnosis, prognosis, treatment selection, and therapy monitoring.
No takes yet. Share an insight, caveat, or question.
Sumel Ashique (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: